Understanding the specific ABCA3 mutations linked to various nRDS phenotypes can inform therapeutic approaches and help families anticipate potential long-term outcomes, including chronic lung disease risks. This evidence concerns the gene ABCA3 and newborn respiratory distress syndrome.